Stay updated on Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added the disease tag 'Malignant pleural mesothelioma' and included the Genetic and Rare Diseases Information Center as a resource; several older update dates were removed.
    Difference
    0.3%
    Check dated 2026-03-18T15:01:24.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. There are no user-visible changes to the study details or layout.
    Difference
    0.0%
    Check dated 2026-03-11T14:44:16.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Added site revision note Revision: v3.4.2. Removed the government funding lapse notice and the previous Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T09:18:19.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    - Added a site-wide notice about a lapse in government funding and updated operating status. - Updated the site version from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T05:17:04.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Added a glossary toggle display and updated footer metadata including Last Update Posted, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Some labels were adjusted for capitalization (No FEAR Act data).
    Difference
    0.2%
    Check dated 2026-01-28T02:44:19.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4, indicating a minor administrative update. The trial details and content appear unchanged.
    Difference
    0.0%
    Check dated 2026-01-14T02:26:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.